Sudarshan Pharma Industries Ltd. - Research Center
543828 SUDARSHAN Group (M) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | |
|---|---|---|
| Sales | 231.80 | 195.49 |
| Operating profit | 8.44 | 6.88 |
| Interest | 3.21 | 2.15 |
| Gross profit | 7.17 | 5.14 |
| EPS (Rs) | 2.03 | 1.96 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | |
|---|---|---|
| Other income | 1.94 | 0.41 |
| Stock adjustment | -2.18 | -2.96 |
| Raw material | 3.14 | - |
| Power and fuel | - | - |
| Employee expenses | 1.61 | 1.08 |
| Excise | - | - |
| Admin and selling expenses | - | - |
| Research and development expenses | - | - |
| Expenses capitalised | - | - |
| Other expenses | 220.79 | 190.49 |
| Provisions made | - | - |
| Depreciation | 0.61 | 0.43 |
| Taxation | 1.67 | - |
| Net profit / loss | 4.89 | 4.71 |
| Extra ordinary item | - | - |
| Prior year adjustments | - | - |
| Equity capital | 24.07 | 24.07 |
| Equity dividend rate | - | - |
| Agg.of non-prom. shares (Lacs) | - | - |
| Agg.of non promotoholding (%) | - | - |
| OPM (%) | 3.64 | 3.52 |
| GPM (%) | 3.07 | 2.62 |
| NPM (%) | 2.09 | 2.40 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis